AKT1 and early-onset autosomal dominant Alzheimer disease: It modulates critical signaling pathways, such as the PI3K/Akt pathway, enhancing PI3K and AKT expression while downregulating GSK-3β, which is crucial in Alzheimer’s disease models, thus promoting cell survival and reducing apoptosis [81].